Evidence map›Paper›PMID 38740760›Full record

ArticleNature communications2024

A cell-free nutrient-supplemented perfusate allows four-day ex vivo metabolic preservation of human kidneys.

Marlon J A de Haan, Marleen E Jacobs, Franca M R Witjas, Annemarie M A de Graaf, Elena Sánchez-López, Sarantos Kostidis, Martin Giera, Francisco Calderon Novoa, Tunpang Chu, Markus Selzner and 9 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Revealing the potential of non-transplanted donor organs: a comparative analysis in the Eurotransplant region.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Article
  9. Review
  10. Time as a Therapeutic Ally: The Promise of Long-Term Solid Organ and Tissue Perfusion.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Beyond preservation: future machine perfusion for liver assessment and repair.Nature reviews. Gastroenterology & hepatology · 2025
    Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Marlon J A de Haan *Department of Internal Medicine (Nephrology) & Einthoven Laboratory of Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0003-4149-9568
Marleen E Jacobs *Department of Internal Medicine (Nephrology) & Einthoven Laboratory of Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0002-0778-4958
Franca M R Witjas *Department of Internal Medicine (Nephrology) & Einthoven Laboratory of Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Annemarie M A de GraafDepartment of Internal Medicine (Nephrology) & Einthoven Laboratory of Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Elena Sánchez-LópezCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0001-8546-766X
Sarantos KostidisCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0002-2040-2563
Martin GieraThe Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0003-1684-1894
Francisco Calderon NovoaAjmera Transplant Centre, Department of Surgery, University Health Network, Toronto, ON, Canada.ORCID http://orcid.org/0000-0003-2637-7909
Tunpang ChuAjmera Transplant Centre, Department of Surgery, University Health Network, Toronto, ON, Canada.
Markus SelznerAjmera Transplant Centre, Department of Surgery, University Health Network, Toronto, ON, Canada.
Mehdi MaanaouiUniversity of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire de Lille (CHU Lille), Institute Pasteur Lille, Lille, France.
Dorottya K de VriesTransplant Center, Leiden University Medical Center, Leiden, The Netherlands.
Jesper KersDepartment of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Ian P J AlwaynTransplant Center, Leiden University Medical Center, Leiden, The Netherlands.
Cees van KootenDepartment of Internal Medicine (Nephrology) & Einthoven Laboratory of Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Bram HeijsThe Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), Leiden University Medical Center, Leiden, The Netherlands.
Gangqi WangDepartment of Internal Medicine (Nephrology) & Einthoven Laboratory of Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands. g.wang@lumc.nl.
Marten A EngelseDepartment of Internal Medicine (Nephrology) & Einthoven Laboratory of Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands. m.a.engelse@lumc.nl.
Ton J RabelinkDepartment of Internal Medicine (Nephrology) & Einthoven Laboratory of Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands. a.j.rabelink@lumc.nl.ORCID http://orcid.org/0000-0001-6780-5186

Funding

Nierstichting (Dutch Kidney Foundation) 20INI011Novo Nordisk Fonden (Novo Nordisk Foundation) NNF21CC0073729
6 · The paper itself

Abstract

The growing disparity between the demand for transplants and the available donor supply, coupled with an aging donor population and increasing prevalence of chronic diseases, highlights the urgent need for the development of platforms enabling reconditioning, repair, and regeneration of deceased donor organs. This necessitates the ability to preserve metabolically active kidneys ex vivo for days. However, current kidney normothermic machine perfusion (NMP) approaches allow metabolic preservation only for hours. Here we show that human kidneys discarded for transplantation can be preserved in a metabolically active state up to 4 days when perfused with a cell-free perfusate supplemented with TCA cycle intermediates at subnormothermia (25 °C). Using spatially resolved isotope tracing we demonstrate preserved metabolic fluxes in the kidney microenvironment up to Day 4 of perfusion. Beyond Day 4, significant changes were observed in renal cell populations through spatial lipidomics, and increases in injury markers such as LDH, NGAL and oxidized lipids. Finally, we demonstrate that perfused kidneys maintain functional parameters up to Day 4. Collectively, these findings provide evidence that this approach enables metabolic and functional preservation of human kidneys over multiple days, establishing a solid foundation for future clinical investigations.

Indexed as

KidneyOrgan PreservationPerfusionAdultAgedCell-Free SystemCitric Acid CycleFemaleHumansKidney TransplantationLipidomicsMaleMiddle AgedNutrientsOrgan Preservation SolutionsNutrientsOrgan Preservation Solutions

Identifiers

PMID38740760
PMCPMC11091145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.